-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, L6o2QdG1/zz8pdVAGAnI1/SJPfoYfl5wtD4oHP1y3/BqJ5p1WSAwwobsT391bARc lRhfdRHPPQYKOsjk1F5+YQ== 0001104659-08-048534.txt : 20080730 0001104659-08-048534.hdr.sgml : 20080730 20080730133115 ACCESSION NUMBER: 0001104659-08-048534 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20080730 DATE AS OF CHANGE: 20080730 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: RELIV INTERNATIONAL INC CENTRAL INDEX KEY: 0000768710 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 371172197 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-48267 FILM NUMBER: 08978306 BUSINESS ADDRESS: STREET 1: 136 CHESTERFIELD INDUSTRIAL BLVD STREET 2: P O BOX 405 CITY: CHESTERFIELD STATE: MO ZIP: 63006-0405 BUSINESS PHONE: 636-537-9715 MAIL ADDRESS: STREET 1: 136 CHESTERFIELD INDUSTRIAL BLVD STREET 2: P O BOX 405 CITY: CHESTERFIELD STATE: MO ZIP: 63006-0405 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN LIFE INVESTORS INC DATE OF NAME CHANGE: 19920315 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Paul & Jane Meyer Family Foundation CENTRAL INDEX KEY: 0001363634 IRS NUMBER: 000000000 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 4527 LAKE SHORE DRIVE CITY: WACO STATE: TX ZIP: 76710 BUSINESS PHONE: 972-788-5300 MAIL ADDRESS: STREET 1: 4527 LAKE SHORE DRIVE CITY: WACO STATE: TX ZIP: 76710 SC 13D/A 1 a08-20306_1sc13da.htm AMENDMENT

 

 

UNITED STATES

 

 

SECURITIES AND EXCHANGE COMMISSION

 

 

Washington, D.C. 20549

 

 

 

 

 

SCHEDULE 13D

 

 

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

 

RELIV INTERNATIONAL, INC.

(Name of Issuer)

 

Common Stock, par value $0.001 per share

(Title of Class of Securities)

 

75952 R 100

(CUSIP Number)

 

Richard A. Tulli, Gardere Wynne Sewell LLP,
1601 Elm Street, Suite 3000, Dallas, Texas 75201, (214) 999-4676

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

July 28, 2008

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §240.13d-1(e), §240.13d-1(f) or §240.13d-1(g), check the following box x.

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See §240.13d-7 for other parties to whom copies are to be sent.

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 


 


 

SCHEDULE 13D/A

 

CUSIP NO. 75952 R 100

 

 

1

NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
The Paul and Jane Meyer Family Foundation

 

 

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 

 

(a)

o

 

 

(b)

x

 

 

3

SEC USE ONLY

 

 

4

SOURCE OF FUNDS*
WC

 

 

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) o

 

 

6

CITIZENSHIP OR PLACE OF ORGANIZATION
Texas

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH

7

SOLE VOTING POWER
2,519,086

 

8

SHARED VOTING POWER
-0-

 

9

SOLE DISPOSITIVE POWER
2,519,086

 

10

SHARED DISPOSITIVE POWER
-0-

 

 

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,519,086

 

 

12

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*o

 

 

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
16.5%

 

 

14

TYPE OF REPORTING PERSON*
CO

 


*SEE INSTRUCTIONS BEFORE FILLING OUT!

INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7

(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.

 

2



 

CUSIP NO. 75952 R 100

 

This Amendment No. 1 to Schedule 13D (this “Amendment”) amends the statement on Schedule 13D filed with the Securities and Exchange Commission on March 21, 2008 (the “Original Schedule 13D”) by The Paul and Jane Meyer Family Foundation (the “Reporting Person”) regarding certain shares (“Shares”) of the common stock, par value $0.01 per share (“Common Stock”), of Reliv International, Inc., a Delaware corporation (the “Issuer”).  This Amendment reflects the Reporting Person’s sales of Shares in the open market through July 17, 2008, and its negotiated private sale of 596,200 Shares to the Issuer on July 28, 2008.

 

Item 4.           Purpose of Transaction.

 

Item 4 of the Original Schedule 13D is amended by adding the following paragraph to the end:

 

The Reporting Person has determined, for its own investment purposes, to reduce its ownership of Shares.  Accordingly, since mid-April, 2008, the Reporting Person has from time to time effected sales of Shares in the open market, and on July 28, 2008, it sold 596,200 Shares to the Issuer in accordance with the Stock Purchase Agreement described in Item 5 and Item 6.

 

Item 5.           Interest in Securities of the Issuer.

 

Item 5 of the Original Schedule 13D is amended to read as follows:

 

(a)                                 At July 28, 2008, the Reporting Person beneficially owned 2,519,086 Shares, representing approximately 16.5% of the outstanding Common Stock of the Issuer.

 

The foregoing percentage is based on 15,277,554 shares of Common Stock outstanding, which is the number of shares of Common Stock reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 9, 2008, less the total 596,200 shares of Common Stock repurchased by the Issuer from the Reporting Person on July 28, 2008.

 

(b)                                The Reporting Person has the sole power to vote or direct the vote of, and the sole power to dispose or direct the disposition of, 2,519,086 shares of Common Stock.

 

(c)                                 Since (and including) May 29, 2008, the Reporting Person has not acquired any shares of Common Stock.  Since (and including) May 29, 2008, the Reporting Person has sold a total 110,600 Shares in open-market transactions on the NASDAQ Global Select Market, as follows:

 

Date of Sale

 

Number of Shares Sold

 

Sales Price Per Share

 

June 16, 2008

 

3,000

 

$

5.83

 

June 17, 2008

 

5,000

 

$

5.85

 

June 18, 2008

 

6,000

 

$

5.81

 

June 19, 2008

 

6,000

 

$

5.83

 

June 20, 2008

 

10,000

 

$

5.71

 

June 24, 2008

 

10,000

 

$

5.73

 

June 26, 2008

 

18,000

 

$

5.66

 

June 27, 2008

 

9,000

 

$

5.56

 

June 30, 2008

 

10,000

 

$

5.53

 

 

3



 

CUSIP NO. 75952 R 100

 

Date of Sale

 

Number of Shares Sold

 

Sales Price Per Share

 

July 1, 2008

 

4,000

 

$

5.45

 

July 2, 2008

 

11,000

 

$

5.15

 

July 3, 2008

 

8,000

 

$

5.16

 

July 7, 2008

 

4,000

 

$

5.16

 

July 8, 2008

 

600

 

$

5.16

 

July 16, 2008

 

2,000

 

$

5.21

 

July 17, 2008

 

4,000

 

$

5.30

 

 

Since (and including) May 29, 2008, the Reporting Person also effected a privately negotiated sale of Shares.  On July 28, 2008, the Reporting Person sold to the Issuer 596,200 Shares for a total of $3,577,200 (i.e., $6.00 per Share) in cash in accordance with the Stock Purchase Agreement dated July 24, 2008, between those parties (the “Stock Purchase Agreement”).  A copy of the Stock Purchase Agreement is filed as Exhibit 1 to this Amendment.

 

(d)                                Not applicable.

 

(e)                                 Not applicable.

 

Item 6.           Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

 

In the Stock Purchase Agreement, the Reporting Person granted the Issuer a right of first refusal regarding each subsequent proposed sale or sales of Shares by the Reporting Person.  The Issuer will have two days to exercise its purchase right as to all or any of the Shares to be sold.  If the Reporting Person proposes to sell in a negotiated transaction, the Issuer may purchase the Shares on the negotiated terms.  If the Reporting Person proposes to sell in the open market, the Issuer may purchase the Shares for cash at a per-Share price equal to the closing price per share of Common Stock on the NASDAQ Global Select Market on the date of the Reporting Person’s notice of proposed sale to the Issuer.  The closing of each purchase by the Issuer will be within five days after the Issuer’s notice of exercise.  To the extent that the Issuer does not exercise its purchase right, the Reporting Person may effect the proposed sale or sales of those Shares within 20 days after the end of the exercise period, and any negotiated sale by the Reporting Person must be on terms no more favorable to the purchaser than the terms offered to the Issuer.

 

On July 25, 2008, Paul J. Meyer, on behalf of himself and the other members of the Board of Directors of the Reporting Person, delivered a letter to the Issuer confirming and agreeing that, until July 25, 2009, those persons will not engage, or encourage or direct any other person to engage, in communication or action adverse to, or in conflict with the actions of, the management of the Issuer.  A copy of this standstill letter is filed as Exhibit 2 to this Amendment.

 

Item 7.           Material to be Filed as Exhibits.

 

Exhibit 1 – Stock Purchase Agreement dated July 24, 2008, between The Paul and Jane Meyer Family Foundation and Reliv International, Inc.

 

Exhibit 2 – Standstill letter to Reliv International, Inc. dated July 25, 2008.

 

4



 

CUSIP NO. 75952 R 100

 

SIGNATURE

 

After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

 

 

July 29, 2008

THE PAUL AND JANE MEYER FAMILY

 

FOUNDATION

 

 

 

 

By:

/s/ Terry Irwin

 

 

Terry Irwin, Vice President

 

5


EX-1 2 a08-20306_1ex1.htm EX-1

 

EXHIBIT 1

 

SCHEDULE 13D/A

 

STOCK PURCHASE AGREEMENT

 

THIS AGREEMENT is entered into this 24th day of July, 2008, by and between the Paul and Jane Meyer Family Foundation, a Texas not for profit corporation, having its principal address at 4527 Lake Shore Drive, Waco, Texas 76710 (“Seller”), and Reliv International, Inc., a Delaware corporation, having its principal place of business at 136 Chesterfield Industrial Boulevard, Chesterfield, Missouri (the “Company”).

 

WHEREAS, Seller is the owner of Five Hundred Ninety-six Thousand Two Hundred (596,200) shares of the common stock of the Company (such shares hereinafter referred to as the “Shares”); and,

 

WHEREAS, Seller desires to sell and Company desires to purchase and redeem all of the Shares on the terms and conditions provided herein.

 

NOW, THEREFORE, in consideration of the premises and of the terms, covenants and conditions hereinafter contained, the parties hereto agree as follows:

 

1.                                       Sale and Purchase of Shares.  Subject to and on the terms and conditions hereof, in reliance on the representations and warranties herein and for the consideration herein, Seller agrees to sell to the Company, and the Company agrees to purchase and redeem from Seller, all of the Shares at the price and on the terms provided herein.

 

2.                                       Purchase Price.  The purchase price for all of the Shares shall be Six Dollars ($6.00) per share or an aggregate of Three Million Five Hundred Seventy-seven Thousand Two Hundred Dollars ($3,577,200).

 

3.                                       Payment.                                              Subject to and on the terms and conditions hereof, and in full payment of the purchase price hereunder, the Company shall, concurrently with the deliveries described in Sections 4.1 and 4.2 below and confirmation of its receipt of the Shares in the Company’s account designated in the instruction letter described below, transfer to an account designated by Seller the aggregate amount of the purchase price for the Shares provided for herein.

 

4.                                       Closing and Transfer.  The Closing of the transactions provided for herein shall be held at the offices of the Company on July 25, 2008, or such later date as may be mutually agreed upon by the parties.  At the Closing:

 

4.1                                 Each party shall deliver to the other a fully executed copy of this Agreement.

 

4.2                                 Seller shall deliver all of the Shares to the Company by transfer of the Shares, through the Depository Trust Company, from Seller’s brokerage account to the Company’s brokerage account; to effect such transfer, Seller will deliver instructions to its securities broker holding the Shares substantially in the form of the instruction letter attached to this Agreement as Exhibit A (or such other form as the parties may agree) and shall provide to the Company a copy of the delivery of such instruction letter to its securities broker at the time of the Closing.

 

4.3                                 The Company shall pay the purchase price for the Shares as provided in Section 3 hereof and shall provide evidence to Seller of the wire transfer of funds for that payment.

 



 

Effective at the time of Closing, the Company shall be entitled to transfer all of the Shares on the books of the Company to the name of the Company.

 

5.                                       Representations and Warranties of Seller.  Seller represents and warrants to the Company, as of the date hereof and as of the Closing, as follows:

 

5.1                                 Seller is the sole owner of, and has good and marketable title to, the Shares free and clear of any and all contracts, options, commitments, agreements, liens, claims or encumbrances whether or not of record.

 

5.2                                 Seller has all necessary corporate power and authority to enter into this Agreement and to perform its obligations hereunder, and this Agreement, and the transactions provided for herein, have been duly and validly authorized by proper action of the Board of Directors of Seller.  This Agreement has been duly executed and delivered by Seller and constitutes a valid and binding obligation of Seller, enforceable against Seller in accordance with its terms.

 

5.3                                 The sale and transfer of the Shares as provided herein will not violate, or constitute a default under, any agreement, commitment, contract, loan, security agreement, pledge or other document or instrument to which Seller is a party or by which Seller or any of the Shares are bound.

 

5.4                                 (i) Seller is fully informed concerning the business, condition, financial and otherwise, assets, operations and prospects of the Company; (ii) Seller, or its representatives, have read and have knowledge of all reports filed by the Company with the Securities and Exchange Commission, including all  Reports on Form 10-K and Form 10-Q, (iii) neither the Company nor any officer, director, agent or representative of the Company has made any representation or warranty, or provided any information, to Sellers concerning or relating to the business, condition, financial or otherwise, assets, operations or prospects of the Company, except as is set forth in the public filings of the Company, and (iv) the market value of the Company’s common stock as traded on the NASDAQ Stock Market, or otherwise, may increase to an amount in excess of the purchase price for the Shares, and nevertheless, Seller has determined and desire to sell the Shares on the terms and at the price provided herein.

 

The representations and warranties of Seller herein shall survive the Closing.

 

6.                                       Representations and Warranties of the Company.  The Company represents and warrants to Seller, as of the date hereof and as of the Closing, as follows:

 

6.1                                 The Company has all necessary corporate power and authority to enter into this Agreement and to perform its obligations hereunder and this Agreement, and the transactions provided for herein, have been duly and validly authorized by proper action of the Board of Directors of this Company.  This Agreement has been duly executed and delivered by the Company and constitutes a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms.

 

6.2                                 The Company has filed all Reports required by it to be filed with the Securities and Exchange Commission, including all Reports on Form 10-K and Form 10-Q.

 



 

6.3                                 The Company has filed, or shall timely file, and make any and all reports or disclosures, required to be made or filed, concerning or related to this Agreement and the transactions provided for herein.

 

6.4                                 The Company’s purchase of the Shares as provided herein will not violate, or constitute a default under, any agreement, commitment, contract, loan, security agreement, pledge or other document or instrument to which the Company is a party or by which the Company is bound.

 

The representations and warranties of the Company herein shall survive the Closing.

 

7.                                       Right of First Refusal.

 

(a)                                  If Seller or any of its Affiliates (as defined in Rule 405 promulgated under the Securities Act of 1933, as amended) shall, at any time, desire to sell some or all of the Remaining Shares in the open market or directly to a third party (the “Third Party”), Seller and/or its Affiliates shall give written notice of such desire to the Company, which notice shall contain the number of shares Seller and/or any of its Affiliates desire to sell, if such sale is to be made in the open market or whether it is a negotiated sale to a Third Party, the proposed terms of the sale and, if the sale is a negotiated sale, the name and address of the Third Party (the “Offer Notice”).  The Company shall have the right of first refusal to acquire all or any portion of the Remaining Shares that Seller and/or any of its Affiliates desire to sell as specified in the Offer Notice (the “Offered Shares”) for a period of two (2) days following the date the Company receives the Offer Notice.  The Company must give any such notice of exercise to Seller within such two-day period.  The Company may freely assign its purchase option in whole or in part. The selling price and terms of any sale of the Offered Shares to the Company or its assignees shall be the same as set forth in the Offer Notice; and if the Offer Notice proposes sales for cash in the open market, then the selling price to the Company or its assignees for each Offered Share will be the closing price per share of the Company’s common stock on the NASDAQ Global Select Market on the date the Offer Notice is given.

 

(b)                                 If the Company does not exercise its right of first refusal within the required two-day period provided above, Seller and/or any of its Affiliates identified in the Offer Notice shall have the right, for a period of twenty (20) days following the expiration of such two-day period, to sell to the Third Party or in the open market, as identified in the Offer Notice, the Offered Shares not purchased by the Company or its assignees; provided, however, that (i) if the sale is to the Third Party, the sale shall be made by Seller and/or any of its Affiliates to the Third Party as identified in the Offer Notice on terms that are no more favorable to the purchaser of such Offered Shares than those set forth in the Offer Notice, and (ii) if such Offered Shares not purchased by the Company or its assignees are not sold by Seller and/or any of its Affiliates in accordance with this Section 7(b) within the twenty (20)-day period described herein, the Offered Shares shall again be subject to the right of first refusal set forth above.

 

(c)                                  The closing pursuant to the exercise of the right of first refusal under Section 7(a) above shall take place no later than five (5) days after the Company shall have notified Seller and any of its Affiliates of the exercise of the right of first refusal and in the same manner as described in Section 4 of this Agreement.

 

(d)                                 If Seller and/or any of its Affiliates transfers any shares of common stock of the Company by gift, it will obtain the donee’s written agreement to comply with the right of first refusal in this Section 7 regarding any further sale of those shares of common stock of the Company.

 



 

8.                                       Specific Enforcement.  The obligations of Seller hereunder are of a special, unique, unusual and extraordinary character, thereby giving this Agreement peculiar value so that the loss of the Shares or violation by Seller of this Agreement could not reasonably or adequately be compensated in damages in an action at law.  Therefore, in addition to other remedies provided by law, the Company shall have the right to compel specific performance hereof by Seller or to obtain injunctive relief against violations hereof by Seller.

 

9.                                       Further Assurances.  Seller and the Company shall take such other and further actions, execute such other and further documents as shall be reasonably necessary or appropriate to effect and consummate the sale contemplated herein.

 

10.                                 Notices.  All notices or other communications required or permitted to be given hereunder shall be in writing and shall be delivered in person, delivered by prepaid courier, mailed by prepaid certified mail (return receipt requested), or transmitted by facsimile, to the parties as follows:

 

 

If to Seller or any of its Affiliates, to:

 

Terry Irwin, Vice President

 

 

Paul and Jane Meyer Family Foundation

 

 

4527 Lake Shore Drive

 

 

Waco, Texas 76710

 

 

Facsimile: (254) 751-7733

 

 

 

If to Company, to:

 

Robert L. Montgomery

 

 

Chief Executive Officer

 

 

Reliv International, Inc.

 

 

136 Chesterfield Industrial Boulevard

 

 

Chesterfield, Missouri 63005

 

 

Facsimile: (636) 537-9753

 

Any notice that is (a) delivered in person or by prepaid courier shall be deemed given, effective, and received upon delivery to (or refusal by) the addressee, (b) mailed shall be deemed given, effective, and received upon the earlier of delivery to (or refusal by) the addressee or the third business day after the date of mailing, and (c) transmitted by facsimile shall be deemed given, effective, and received upon receipt by the addressee as confirmed by the facsimile transmission report.

 

11.                                 Entire Agreement.  This Agreement constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and supersedes all prior written or oral warranties, representations, inducements, understandings, commitments, agreements or contracts.  This Agreement may not be modified except by a writing signed by both of the parties.

 

12.                                 Binding Effect.  This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective, heirs, personal representatives, successors and assigns.

 

13.                                 Governing Law; Jurisdiction.  This Agreement shall be governed by and construed and enforced in all respects in accordance with the laws of the State of Missouri.  This Agreement shall be deemed to have been executed in the State of Missouri and the courts of the State of Missouri, County of St. Louis, or the courts of the United States of America for the Eastern District of Missouri, shall have exclusive jurisdiction of any case, action or proceeding arising under or related to this Agreement.  Each of the parties hereto consents to the jurisdiction of such courts with respect to any such case, action or

 



 

proceeding and further consents to service of process in any action filed by the other party by certified mail at the address of the party set forth herein.

 

[Remainder of page intentionally left blank.]

 



 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement effective as of the day and year first above written.

 

 

 

RELIV INTERNATIONAL, INC.

 

 

 

 

 

By:

/s/Robert L. Montgomery

 

 

 

    Robert L. Montgomery, CEO

ATTEST:

 

 

/s/ Steven D. Albright

 

 

Vice-President

 

 

 

 

 

 

 

PAUL AND JANE MEYER FAMILY FOUNDATION

 

 

 

 

 

By:

/s/ Terry Irwin

 

 

 

     Terry Irwin, Vice President

 



 

Paul & Jane Meyer Family Foundation

4527 Lake Shore Drive

Waco, Texas 76710

 

July      , 2008

 

 

[Seller’s securities broker]

 

Re:          Transfer of Shares of Reliv’ International, Inc.

 

Ladies and Gentlemen:

 

The undersigned is the holder of          shares (the “Shares”) of common stock of Reliv’ International, Inc., a Delaware corporation (“Reliv”), CUSIP No. 75952 R 100, EIN 37-1172197.

 

You are hereby instructed to transfer and deliver the Shares, against payment, via Depository Trust Company  (“DTC”) to [name of Reliv’s broker (“Broker”),] having DTC Participant No.         , on July          , 2008.  The Shares are being transferred for registration unto [Broker] Account No.          for the benefit of Reliv.  In exchange for the transfer of the Shares to [Broker], you are to receive for the undersigned’s account payment in the amount of $3,577,200.

 

 

 

PAUL & JANE MEYER FAMILY FOUNDATION

 

 

 

By:

 

 

 

Terry Irwin, Vice President

 


EX-2 3 a08-20306_1ex2.htm EX-2

 

EXHIBIT 2

 

SCHEDULE 13D/A

 

July 25, 2008

 

Reliv International, Inc.

136 Chesterfield Industrial Blvd.

Chesterfield, Missouri 63005

Attn:   Robert L. Montgomery,

Chief Executive Officer

 

Gentlemen:

 

On behalf of myself and the other members of the Board of Directors of The Paul & Jane Meyer Family Foundation (the “Foundation”), we confirm and agree that, for a period of one year from the date of this letter, we will not engage, or encourage or direct any other person to engage, in communication or action adverse to, or in conflict with the actions of, the management of Reliv International, Inc. (the “Company”).  This covenant will not, however, impair or affect the Foundation’s sale or transfer of shares of common stock of the Company, subject to the Foundation’s compliance with its obligations under the Stock Purchase Agreement between the Foundation and the Company dated as of July 24, 2008 (the “Stock Purchase Agreement”), or the Foundation’s exercise of any of its rights and remedies under or relating to the Stock Purchase Agreement.

 

 

Sincerely,

 

 

 

/s/ Paul J. Meyer

 

 

 

Paul J. Meyer

 


-----END PRIVACY-ENHANCED MESSAGE-----